Device
OCS Lung System
OCS Lung System is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
not_yet_recruiting125%
active_not_recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Decreasing Edema With a Novel OCS Solution Trial
NCT07340710
active_not_recruiting
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
NCT03639025
completed
INSPIRE Continuation Post-Approval Study
NCT03868904
completed
OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
NCT04194398
Clinical Trials (4)
Showing 4 of 4 trials
NCT07340710Not Applicable
Decreasing Edema With a Novel OCS Solution Trial
NCT03639025
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
NCT03868904
INSPIRE Continuation Post-Approval Study
NCT04194398
OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4